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Los Angeles CountyAbstract Carriers of the pork tapeworm, Taenia solium, are the sole source of
neurocysticercosis, a parasitic tissue infection that can be chronic and severe.
Identifying T. solium tapeworm carriers is challenging. Many are asymptomatic
and go undetected and unreported. In addition, T. solium is difficult to distinguish
from other Taenia species of less concern. From 2009 to 2014, 24 taeniasis cases
were reported to the Los Angeles County (LAC) Department of Public Health.
Twenty reports were received solely from our automated electronic laboratory
reporting system (ELR), two from health care providers, and two were generated
internally from investigation of households with a reported neurocysticercosis case.
Further investigation identified one T. solium carrier originally reported by ELR and
one identified from a neurocysticercosis case investigation. These results suggest
that T. solium tapeworm carriers can be identified from investigation of ELR reports
of unspeciated Taenia cases as well as from households of neurocysticercosis cases.
Published by Elsevier Ltd. on behalf of Ministry of Health, Saudi Arabia. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Carriers of the pork tapeworm, Taenia solium, are
the sole source of cysticercosis, a parasitic tissue
infection [1]. When tapeworm eggs excreted by
the carrier are ingested, tapeworm larvae can form
cysts. When cysts form in the brain, the condition
is called neurocysticercosis and can be especiallysevere. The burden of neurocysticercosis in Los
Angeles County (LAC) is appreciable, with an aver-
age of 136 county residents hospitalized annually
[2]. The prevalence of T. solium carriage is largely
unknown because carriers are generally asymp-
tomatic, making detection difficult. The identifica-
tion and treatment of tapeworm carriers is an
important public health measure that can prevent
further neurocysticercosis cases [1].
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automated electronic laboratory reporting system
(ELR) has recently been recognized. These cases
were not identified by a LAC Department of
Public Health (DPH) neurocysticercosis investiga-
tion, which has been the source of such reports in
the past [3]. These ELR reports are generally based
on the identification of Taenia eggs which are
morphologically indistinguishable between Taenia
species. Therefore, ELR reported Taenia cases
may not be the species of public health interest
(T. solium). Speciation can be performed at our
public health laboratory, but can be challenging.
We performed a retrospective review of all
taeniasis cases reported over the last 6 years in
LAC. Case demographics, laboratory information
and reporting source were reviewed.
2. Methods
Cases reported to the LAC DPH from 2009 to 2014
with supportive laboratory documentation were
identified for review. Laboratory supportive evi-
dence included (1) Taenia eggs identified via
microscopy exam of stool performed at a private
or our public health laboratory or (2) serological
testing for T. solium antibodies specific for the
tapeworm form using Enzyme-linked Immune-elec-
tro Transfer Blot (EITB) performed at the Center
for Disease Control (CDC). Taeniasis case demo-
graphics and rates were calculated using popula-
tion data provided by Urban Research [4],
excluding LAC regions of Pasadena and Long
Beach which are served by their own respective
health departments. Taenia speciation, reporting
source and birth place of cases were also reviewed.
Medical, laboratory and DPH nursing records were
reviewed where available. All effort was made to
protect the personal health information of cases
and all data were analyzed anonymously.
3. Results
3.1. Demographics (N = 24)
There were 24 taeniasis cases identified in LAC
from 2009 to 2014, with an average annual rate
of 4.1 per 10 million residents. Cases were much
more likely to be male than female (79.2% vs.
20.8%) (Table 1). The average age of a case was
43.0 years (range 3–70 years). Many cases were
Hispanic (37.5%) and a majority resided in the San
Fernando Service Planning Area (58.3%). The
annual rate of taeniasis was higher for men (6.5
per 10 million) and for persons age 35–44 years
(9.5 per 10 million) and persons age 65 years andolder (8.3 per 10 million). Asians had the highest
rate of taeniasis by race ethnicity (7.7 per 10 mil-
lion) and the San Fernando Valley Service
Planning Area of LAC had the highest rate by
geographic region (10.6 per 10 million).
3.2. Epidemiology (n = 14)
Prior to 2011, only basic demographic and testing
information was captured with the taeniasis survey
tool utilized. The survey tool was updated in 2011
and detailed birthplace, symptoms, treatment
and employment information for the 14 cases
occurring after this change. Of these, 13 were born
outside of the US; Mexico (n = 6), Cuba (n = 1),
Nicaragua (n = 1), Vietnam (n = 1), Italy (n = 1),
Ethiopia (n = 1) Iran (n = 1) and Guatemala (n = 1).
The one US born case frequently traveled to
South East Asia for business trips. The average time
for a case to have lived in the US before being diag-
nosed was 11 years (ranging 0–36 years). None of
these cases were employed as a food handler.
Mild gastrointestinal symptoms were reported
by seven of the 14 cases (i.e. stomach cramps,
nausea). Of the seven cases that did not report
gastrointestinal symptoms, four observed ‘‘worms
in their stool’’ and sought medical attention. All
14 cases received treatment, which included
praziquantel (n = 13) and albendazole (n = 1) and
mebendazole (n = 1), with one case receiving mul-
tiple treatments over a two-year period. This case
was initially treated with praziquantel (600 mg)
followed by two additional treatments with alben-
dazole (100 mg both times) from a private provi-
der and a forth treatment of praziquantel
(600 mg) from a county clinic. The case reported
no worms one year after the fourth treatment,
but declined further stool testing. The case
reported no travel outside the US during this
two-year period.
3.3. DPH notification source (N = 24)
Twenty of the 24 taeniasis cases were reported
solely by ELR (83.3%). No health care provider noti-
fication was ever submitted. Further investigation
of these ELR reports identified one T. solium case.
This was a 60 year-old male who had emigrated
from Ethiopia 20 years earlier and was reported
with Taenia eggs in one of three stool specimens
tested by a private lab. Three additional stool
specimens collected from this case and tested at
the public health lab identified a T. solium proglot-
tid in one specimen. This case reported abdominal
pain and was diagnosed with distention. Treatment
consisted of a single dose of praziquantel (600 mg).
Table 1 Taenia tapeworm carrier demographics and rates for cases reported in Los Angeles County, California from 2009
to 2014.
N Case distribution (%) Average annual rate
per 10,000,000 population
All reports 24 100 4.1
Gender
Male 19 79.2 6.5
Female 5 20.8 1.7
Age
15–34 8 33.3 4.6
35–44 8 33.3 9.5
45–64 3 12.5 2.2
65+ 5 20.8 8.3
Race ethnicity
Hispanic 9 37.5 3.2
White 5 20.8 2.9
African or African American 4 16.7 7.4
Asian or Pacific Islander 6 25.0 7.7
Residence (SPA)
San Fernando Valley (2) 14 58.3 10.6
San Gabriel Valley (3) 2 8.3 2.0
Metro (4) 6 25.0 7.7
Other LAC (1, 5, 6, 7) 2 8.3 1.1
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ment did not identify evidence of Taenia and the
case was considered cleared of infection. Two
additional family members were also screened for
Taenia tapeworms. No evidence of Taenia was
identified from any of the three stool specimens
collected from each family member and the inves-
tigation was closed.
Another public health investigation of an ELR
reported taeniasis case identified this person with
a Taenia saginata tapeworm. This case was a
37 year-old female who emigrated from Guatemala
nine years earlier. Three additional specimens col-
lected by a public health nurse and examined in
our public health laboratory. The laboratory identi-
fied a T. saginata proglottid in one specimen. This
case was referred for treatment, but no additional
follow-up or testing was performed as T. saginata
is not of public health interest. Speciation was
attempted on four additional taeniasis cases
reported by ELR, but no worm segments were iden-
tified to speciate. These four cases, and the remain-
ing unspeciated Taenia cases, were referred for
treatment. No additional stool collection or testing
was performed by LAC DPH.
Two taeniasis cases (8.3%) were identified from
two separate public health investigations of provi-
der reported neurocysticercosis cases. Oneneurocysticercosis investigation involved an
18 year-old case with recent onset of seizures
and evidence of neurocysticercosis by magnetic
resonance imaging. A 44 year-old Hispanic male
living in the household and emigrating from
Mexico 12 years earlier was identified with evi-
dence of T. solium tapeworm (EITB). This tape-
worm case was treated with one dose of
praziquantel (600 mg) and the investigation was
closed. The second neurocysticercosis investiga-
tion involved a 33 year-old female case suffering
from hydrocephalus, with positive cysticercosis
serology and magnetic resonance imaging suggest-
ing neurocysticercosis. A 37-year old Hispanic
female emigrating from Guatemala eight years
earlier was identified with Taenia eggs in one of
three stool specimens by our public health labora-
tory. The tapeworm case was treated with 600 mg
of praziquantel. Three stool specimens collected
1 month post treatment found no evidence of
Taenia and the investigation was closed. Details
of this case have previously been reported [5].
Two taeniasis cases (8.3%) were reported by pri-
vate health care providers; one from a county refu-
gee clinic and one from a county hospital. Both
cases were referred for treatment by a LAC DPH
nurse, but no further stool collection or testing
was performed by DPH.
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Taeniasis appears to be a rare disease in the LAC,
but the asymptomatic nature of the disease makes
any estimation of the true prevalence difficult.
Cases in the US have been identified previously
through screening at risk populations [6,7] and by
screening household members of neurocysticerco-
sis cases [3,8–11]. Taeniasis rates in LAC appear
higher for men than women. This gender trend
appears consistent with neurocysticercosis mortal-
ity in the US, with men comprising 62% of the
deaths [12]. If men are more likely to travel and
eat higher risk foods, this may put them at a higher
risk of taeniasis or exposure to a taeniasis case.
Whereas other studies indicate that taeniasis in
the US primarily affects Latinos [6,7] our study
indicated that other race-ethnicities are also
impacted.
Taeniasis cases are increasingly being reported
by our automated electronic submission of labora-
tory reports (ELR) that are not accompanied by a
provider report and have no known association
with a neurocysticercosis case. In this review, a
majority of reports were received in this manner,
with one case identified with T. solium tape-
worm. Reporting of taeniasis by providers is man-
dated by law in California; however reporting
from laboratories is currently voluntary.
Mandatory laboratory reporting will ensure that
public health departments continue to receive
these ELR reports and have the opportunity to
identify T. solium carriers. DPH should ensure
that T. solium cases are not working as a food
handler, receive adequate treatment and are
cleared of infection.
One T. solium carrier and one T. saginata case
discussed in this review were identified by light
microscopy exam of stool performed at our public
health laboratory. This method has a low sensitiv-
ity for detecting taenia tapeworms [13], however,
most private laboratories utilize this method and it
is indicative of active infection. Further speciation
requires either identification of the tape worms
scolex (tapeworm attachment mechanism) or iden-
tification and enhancement of the tapeworms
proglottid (tapeworm segment containing repro-
ductive organs) and is best when performed on a
stool specimen collected in a saline solution with
no preservative. Stool specimens collected for
ovum and parasite testing are typically collected
in a formalin solution that renders them non-infec-
tious, but often degrades the worm segment and
makes them difficult to speciate. Speciation is usu-
ally only performed at a public health lab.One T. solium tapeworm carrier was identified
with a positive EITB serological test performed at
the CDC. This test has superior sensitivity to micro-
scopy exams, is capable of distinguishing the tape-
worm form from the larval form of T. solium and
can distinguish T. solium from other taenia species
[14]. It also eliminates any possible exposure of
the case or laboratory personnel to the tapeworm
eggs while collecting and testing stool specimens.
T. solium eggs are directly infectious to humans.
However, this method cannot distinguish current
from recent infection and is not commercially
available [13].
It is difficult to speculate how many of the 21
unspeciated Taenia cases presented in this review
were T. solium carriers. Studies of taeniasis
cases globally suggest that T. saginata tapeworm
infection is much more common than T. solium
tapeworm infection (50 vs. 5 million, 1996) [15],
indicating that many of the taeniasis cases in our
study may actually have a T. saginata infection
and are not of public health interest.
With improved collaboration between public
health, private laboratories and private health care
providers, cases of neurocysticercosis can be pre-
vented through the identification and successful
treatment of T. solium tapeworm carriers. Public
health needs to be part of this process; speciating
cases when possible and ensuring that T. solium
cases are successfully treated and cleared of infec-
tion. Hopefully, improved laboratory techniques
will become more available to public health
laboratories.
Much of the laboratory and medical information
presented in this study was collected retrospec-
tively, which has inherent limitations. In addition,
the rates of taeniasis presented in this review by
demographics may be unstable due to the small
number of cases. The capabilities and techniques
of private labs to correctly identify and report
Taenia using microscopy exams of stools may vary,
which would influence the cases reported in this
review.Conflict of interest
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